Monday, 25 November 2013

NIH mouse study finds gut microorganisms may determine cancer treatment outcome

An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute, part of the National Institutes of Health, and their collaborators. Read more here.

Study mentioned: Iida N, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013 Nov 22;342(6161):967-70. PMID: 24264989

No comments:

Post a Comment